1. Exemestane, a new steroidal aromatase inhibitor of clinical relevance;Lombardi;Biochim. Biophys. Acta Mol. Basis Dis.,2002
2. Pazopanib;Beljanski;xPharm Compr. Pharmacol. Ref.,2010
3. Pazopanib: the newest tyrosine kinase inhibitor for the treatment of advanced or metastatic renal cell carcinoma;Keisner;Drugs,2011
4. “Exemestane | 107868-30-4.” https://www.chemicalbook.com/ChemicalProductProperty_EN_CB5760314.htm (accessed Oct. 25, 2021).
5. A review of the use of exemestane in early breast cancer;Robinson;Ther. Clin. Risk Manag.,2009